Freshfields Bruckhaus Deringer LLP advises on compensation elements of complex global transactions, led by Lori Goodman, Nicole Foster , and Sarah Ghulamhussain. The team has standout expertise in structuring executive pay in transformative M&A deals, IPOs, and corporate governance matters. With a strong focus on cross-border transactions, the firm seamlessly navigates complex compensation frameworks across multiple jurisdictions. Jordan Salzman, based in New York, advises public companies and private equity funds on employee benefit and compensation issues in mergers, acquisitions, spinoffs, IPOs, and other corporate transactions. The practice is also deeply experienced in advising public companies on governance, incentive structures, and regulatory developments.
Legal 500 redaktioneller Kommentar

Kernmandanten

  • Johnson & Johnson
  • AstraZeneca
  • Zeus Industrial Products Inc.
  • The Yokohama Rubber Company, Limited
  • Grunenthal GmbH
  • Novartis International AG
  • Sonoco Products Company
  • JT International SA
  • JD Sports Fashion Plc
  • Aristocrat Technologies, Inc.

Highlight-Mandate

  • Advised Johnson & Johnson (NYSE: JNJ) on its $13.1 billion acquisition of Shockwave Medical, Inc., a leading, first-to-market provider of innovative intravascular lithotripsy technology.
  • Represented AstraZeneca on an unprecedented series of major M&A transactions over a series of a few months.
  • Advised Zeus Company on its sale to EQT Partners.

Anwält*innen

Führende Partner*innen

Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.

Nicole Foster

Führende Associates

Führende Associates sind regelmäßig an zentralen Mandaten des Teams beteiligt und erhalten positives Feedback von Wettbewerbern oder Mandanten.

Jordan Salzman

Praxisleitung

Nicole Foster; Lori Goodman; Sarah Ghulamhussain

Weitere Kernanwält*innen

Jordan Salzman